Miami Cancer Institute Names Chief Operating Officer Mark Davis, M.D., Expert in Domestic and Global Health Operations
MIAMI, FL ― August 11, 2021 ― Operational strategist and physician, Mark Davis, M.D., M.S., has been appointed chief operating officer at Miami Cancer Institute, part of Baptist Health South Florida. Dr. Davis comes from Brigham and Women’s Hospital in Boston, Massachusetts, where he was vice president of Brigham Health International, leading academic collaborations between Brigham and multiple international parties, and executive director of Business Development and Strategic Initiatives, working on health system and hospital design, education, research and operations both nationally and internationally. He served most recently as senior advisor of Strategic Initiatives and Partnership and also an associate professor of emergency medicine at Harvard Medical School.
Dr. Davis has more than 20 years of experience as a national and global health leader and emergency medicine physician. In collaboration with the Dana-Farber Cancer Institute, he helped establish a multi-billion-dollar advanced cancer hospital in China. He has served as a visiting scientist at NASA Johnson Space Center, an international ambassador to Romania and Israel through the American College of Emergency Physicians, and a member of the World Health Organization’s Essential Trauma Care Program Steering Committee. He has also advanced telehealth platforms internationally and among Native American underserved populations.
At Miami Cancer Institute, part of Baptist Health South Florida, Dr. Davis will be responsible for operational excellence and patient-centered care, playing a key role in developing long-term strategy in the areas of clinical care and technical advances, as well as navigating the complex financial environment faced by healthcare organizations today.
“Since its opening in 2017, the Institute has grown to become one of the largest cancer programs in the state in terms of patient volume,” said Michael J. Zinner, M.D., CEO and executive medical director. “Dr. Davis has a deep commitment to clinical quality, patient safety and efficiency in the delivery of healthcare. We are excited to have someone with his expertise on board as we continue our phenomenal growth, offering new services and expanding our research programs, opening additional locations in South Florida and internationally, and developing and acquiring the latest technologies.”
Dr. Davis received his medical degree from the University of Pennsylvania School of Medicine, where he was recognized with the Medical Scholar award in 1990. He also has a master’s degree from the University of Pennsylvania Graduate School of Education. He completed an internship and residency in emergency medicine at the University of California, Los Angeles Medical Center.
His numerous honors include the Humanitarian Award from the Hippocrates Society, Brigham and Women’s Hospital; the Best Faculty Clinician Award, Harvard Affiliated Emergency Medicine Residency Program, Brigham and Women’s Hospital; and an International Emergency Medicine Fellowship Award from the Ronald Reagan Institute of International Emergency Medicine, George Washington University School of Medicine.
Dr. Davis serves on the editorial boards of many professional journals and has served as reviewer for such publications as the Physician Leadership Journal, Annals of Emergency Medicine, American Journal of Emergency Medicine, European Journal of Emergency Medicine and Biomed Central.
Dr. Davis and his wife, Lauren Harshman Davis, M.D., a medical oncologist who works in the biotechnology industry, have two sons, enjoy the outdoors, traveling and walking their dogs.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with 11 hospitals, more than 23,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.
# # #
